申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:EP0127189A2
公开(公告)日:1984-12-05
Use of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline or a pharmaceutically acceptable saltthereoffor prophylaxis and/or treatment of peptic ulcer, and a method for prophylaxis and/or treatment of peptic ulcer disease which comprises administering an effective amount of the above-mentioned compound to warm blood animal, especially human. Said active compounds have excellent pharmacological activities such as inhibition of ulceration and inhibition of gastric secretion, and hence, are useful as an anti-peptic ulcer agent.
2-(4-乙基-1-哌嗪基)-4-苯基喹啉或其药学上可接受的盐用于预防和/或治疗消化性溃疡的用途,以及一种预防和/或治疗消化性溃疡病的方法,该方法包括向温血动物,特别是人,施用有效量的上述化合物。上述活性化合物具有良好的药理活性,如抑制溃疡和抑制胃液分泌,因此可用作抗消化性溃疡剂。